See inside every stock. Pro
S&P 5007,723▲ 0.60%Nasdaq26,478▲ 1.18%Dow Jones52,378▲ 0.03%Nasdaq 10029,651▲ 1.29%VIX17.52▼ 4.73%US Dollar102.35▲ 0.39%Gold spot4,006▲ 0.30%WTI101.94▲ 2.04%
← ATEME page
XStocksXray
Market X-Ray report · 27 October 2026

ATEME SA (ATEME)

Euronext Paris · France · prices in EUR · close of 27 Oct 2026

Key indicators

Last closeEUR 11.60
52-week range5.18 – 14.10
Return, 1 month / 3 months−9.0% / −7.6%
Return, 1 year / 3 years+108.6% / +76.8%
TrendAbove 200-day, below 50-day
RSI (14)49
Volatility (1 year)52.4%
Worst drawdown (1 year)-25.9%
Average daily value traded0.17M EUR
Dividend yield–

Market X-Ray price-based

71/ 100 · High confidence · ahead of 86% of stocks on this exchange
Trend84
Momentum78
Stability (higher is calmer)52
Liquidity67
Income–

Five-year price chart navy: price · brown: 200-day average

2.285.458.6311.8114.982021-112023-022024-052025-082026-10

About the company

ATEME is a French technology company that develops video compression and delivery systems for television broadcasters, pay-television operators and streaming content providers. Its products include encoders, video processing equipment and software that help customers deliver live and on-demand video over satellite, cable, terrestrial and internet networks. The company is based in France and works with media organisations that need to transmit high-quality video efficiently across their distribution systems.

The shares are listed on the Euronext Paris in France under the code ATEME, and the price on this page is in euros (EUR). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.

Summary

ATEME SA (ATEME) trades on the Euronext Paris in France. It last closed at EUR 11.60 on 27 October 2026.

Its price-based Market X-Ray is 71 out of 100 (a strong price profile), ranking 89 of 625 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.

Over the last year the price rose 108.6% and over the last three months it fell 7.6%. Returns are price returns, dividends not included.

Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.

stocksxray.com · page 1
XStocksXray
ATEME SA (ATEME)

The five lenses in numbers each metric is ranked against the other stocks on Euronext Paris

Lens and metricValueScoreReading
Trend84 · StrongTrading above its long-term averages and near its highs.
Above 200-day average8.7%
From 52-week high-16.5%
Momentum78 · StrongRising faster than most stocks on this exchange.
3-month return-7.6%
6-month return10.5%
12-month return, skipping the last month129.3%
Stability (higher is calmer)52 · FairTypical risk for this exchange.
Volatility, 1 year (lower is calmer)52.4%
Worst drawdown, 1 year (smaller is calmer)-25.9%
Liquidity67 · FairModerate trading activity.
Average daily value traded0.17M EUR
Zero-volume days0.0%
Income–Pays no dividend.
Dividend yield–
Years with dividends0

Strengths

  • Trend: Trading above its long-term averages and near its highs.
  • Momentum: Rising faster than most stocks on this exchange.

Weak spots

No lens is weak against its exchange.

Returns

1 week+2.2%
1 month−9.0%
3 months−7.6%
6 months+10.5%
1 year+108.6%
3 years+76.8%
5 years−15.9%

Signals

50-day / 200-day average12.04 / 10.67
Golden / death cross (60 days)None
New 52-week highNo
Bullish RSI divergenceNo
Average daily range (ATR)0.45

Technical summary

DailyNeutral7 bullish · 2 neutral · 7 bearish
WeeklyNeutral6 bullish · 1 neutral · 5 bearish
MonthlyStrongly bullish7 bullish · 1 neutral · 0 bearish

How to read this report

Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Euronext Paris; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.

stocksxray.com · page 2 · generated 28 Oct 2026